GreenLight Biosciences Holdings, PBC
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | $6.8M | $1.6M | — |
| Operating income | −$163.9M | −$13.1M | −$2,528 |
| Net income | −$167.1M | −$15.1M | −$2,528 |
| Total assets | $148.6M | $207.5M | $337,875 |
| Total liabilities | $100.5M | $28.2M | $302,528 |
| Equity | $48.1M | −$27.7M | $22,472 |
| EPS (diluted) | $-1.27 | $-1.17 | — |
| Shares out. | 122.8M | 96.6M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −2417.7%
- Net margin
- −2463.9%
- Return on equity
- −347.6%
- Return on assets
- −112.4%
- Return on capital (ROCE)
- −145.0%
- Liabilities / assets
- 67.7%
- Debt / equity
- 2.09×
- Book value / share
- $0.39
- Revenue growth (YoY)
- 325.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -14.56distress
- Accruals / assets
- −20.4%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 17, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJul 24, 2023
- Costs from exit or disposalMay 31, 2023
- Entered a material agreement · New financial obligation · Other material eventMay 30, 2023
- Results of operationsMay 11, 2023
- Regulation FD disclosureMar 30, 2023
- Results of operationsMar 28, 2023
- Regulation FD disclosure · Other material eventMar 9, 2023
- Regulation FD disclosure · Other material eventMar 7, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GAug 11, 2023
- SC 13D/AJul 28, 2023
- SC 13D/AAMENDMENT TO SCHEDULE 13DJul 28, 2023
- 8-K/AJul 28, 2023
- SC 13D/AJul 27, 2023
- 4Jul 27, 2023
- 3Jul 27, 2023
- 4PRIMARY DOCUMENTJul 27, 2023
- 4PRIMARY DOCUMENTJul 27, 2023
- 4PRIMARY DOCUMENTJul 27, 2023
- SC 13D/AJul 27, 2023
- 4Jul 26, 2023
- 4Jul 26, 2023
- 3Jul 26, 2023
- 4Jul 26, 2023